Levisetti Matteo 4
4 · Cue Biopharma, Inc. · Filed Jan 19, 2023
Insider Transaction Report
Form 4
Levisetti Matteo
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2023-01-17+110,000→ 110,000 totalExercise: $3.36Exp: 2033-01-16→ Common Stock (110,000 underlying)
Footnotes (1)
- [F1]This stock option grant becomes exercisable in eight equal semi-annual installments beginning on 7/17/2023